ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 181

A Vascular Obstacle in Ultrasound Guided Hip Joint Injection

MaryAnn Zhang1, Monica Pessina2, Jay B. Higgs3 and Eugene Y. Kissin4, 1Internal Medicine, Boston University School of Medicine, Boston, MA, 2Anatomy, Boston University School of Medicine, Boston, MA, 3Rheumatology Service, Brooke Army Medical Center, San Antonio, TX, 4Boston University School of Medicine, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Anatomy, Hip, Joint procedures, radiology and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Imaging of Rheumatic Diseases Poster I: Ultrasound, Optical Imaging and Capillaroscopy

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Injury of the lateral circumflex femoral artery (LCFA) is a potential cause of bleeding during invasive hip procedures due to its close proximity to the femoral acetabular joint. However, the LCFA is not routinely cited as a structure to avoid during intra-articular hip injections. The purpose of this study was to evaluate the risk of LCFA injury during ultrasound guided hip joint injection.

Methods:

1) We searched the PUBMED database (1967 to Apr 2015) for existing literature on basic techniques for ultrasound guided hip joint injection using the following search string: [“injection” OR “arthrocentesis” OR “aspiration”] AND [“hip” OR “intra-articular” OR “acetabulofemoral” OR “coxofemoral”] AND [“ultrasound” OR “ultrasonography” OR “ultrasound-guided” OR “image-guided”]. 52 non-English studies were excluded. 5 textbooks on musculoskeletal ultrasound were also reviewed. Resulting literature was screened for mention of the LCFA. 2) 18g spinal length needles were inserted under ultrasound guidance into the hip joints of 4 human cadavers. The tissues were dissected with the needles in place to expose the LCFA in relationship to the needle. 3) Rheumatologists trained for 8 months in ultrasound used electronic calipers to mark a planned needle trajectory from skin to hip joint on a live human ultrasound image during a musculoskeletal ultrasound final Observed Structured Clinical Examination (OSCE). Doppler imaging was subsequently used to locate the LCFA, and the closest distance between the planned needle trajectory and arterial signal was recorded.

Results:

1) 709 articles and 5 textbook chapters were reviewed; 11 discussed the technique of ultrasound guidance for hip injection. Of these 11 citations, 7 highlighted the femoral vascular bundle as a structure to avoid but only one specified routine use of Doppler imaging or specifically to avoid the LCFA. 2) In 3 out of the 4 human cadaveric dissections, the needle inserted into the hip under ultrasound guidance also made direct contact with the LFCA. 3) Of 27 OSCE participants, only 2 chose to activate Doppler imaging before marking their simulated hip injection trajectory. The electronic needle trajectory markings were subsequently found to pass through LFCA region Doppler signal in 6 (22%) cases. Among all 27 participants, the mean shortest distance from needle trajectory to arterial signal was 4mm (range 0-11mm).

Conclusion:

The risk of LCFA injury during ultrasound guided hip joint injection is substantial. Although the clinical significance of LCFA injury remains unclear, for high risk individuals (such as those on chronic anticoagulation), we suggest routine use of Doppler imaging as a part of standard hip injection protocols. Further study is required to determine if a more oblique or transverse approach to the hip will reduce the risk of accidental vascular injury.


Disclosure: M. Zhang, None; M. Pessina, None; J. B. Higgs, None; E. Y. Kissin, None.

To cite this abstract in AMA style:

Zhang M, Pessina M, Higgs JB, Kissin EY. A Vascular Obstacle in Ultrasound Guided Hip Joint Injection [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/a-vascular-obstacle-in-ultrasound-guided-hip-joint-injection/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-vascular-obstacle-in-ultrasound-guided-hip-joint-injection/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology